title: Inhibitory mechanism by polysialic acid for lamina-specific branch formation of thalamocortical axons.
abstract: During development, thalamocortical axons form arbors primarily in layer 4 of the neocortex. This lamina-specific branch formation was studied in cultures of rat thalamic explants grown next to chemically fixed cortical slices. After a week in vitro, thalamic axons formed branches specifically in the target layer of fixed cortical slices, regardless of the orientation of the ingrowth. This in vitro system permits a direct assessment of contributions of membrane-associated molecules to thalamic axon branch formation. To this end, the present study uses three enzymatic perturbations: chondroitinase, phosphatidylinositol phospholipase C, or the polysialic acid (PSA)-specific endoneuraminidase (endo N). With endo N pretreatment of cortex, the number of branch points was increased significantly, whereas branch tip length was decreased. In addition, the localization of branch points to the target layer was weakened considerably. These features of branch formation were not altered by the other two enzymatic treatments, except that branch tips were shortened by chondroitinase treatment to the same extent as in endo N treatment. These results suggest that membrane-bound components are involved in lamina-specific branch formation of thalamocortical axons, and in particular that PSA moieties contribute to laminar specificity by inhibiting branch emergence in inappropriate layers.
authors: Division of Biophysical Engineering, Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan. nob-yama@bpe.es.osaka-u.ac.jp
authors: N
authors: N
authors: Yamamoto
authors: K
authors: K
authors: Inui
authors: Y
authors: Y
authors: Matsuyama
authors: A
authors: A
authors: Harada
authors: K
authors: K
authors: Hanamura
authors: F
authors: F
authors: Murakami
authors: E S
authors: ES
authors: Ruthazer
authors: U
authors: U
authors: Rutishauser
authors: T
authors: T
authors: Seki
mesh_terms: D000818:Animals; D001369:Axons / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D001485:Basement Membrane / Q000648:ultrastructure; D002454:Cell Differentiation; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology* / Q000378:metabolism; D002810:Chondroitinases and Chondroitin Lyases / Q000378:metabolism / Q000494:pharmacology; D018920:Coculture Techniques / Q000379:methods; D006026:Glycoside Hydrolases / Q000378:metabolism / Q000494:pharmacology; D007150:Immunohistochemistry; D018613:Microscopy, Confocal; D009010:Monte Carlo Method; D009434:Neural Pathways / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D051381:Rats; D012794:Sialic Acids / Q000378:metabolism / Q000494:pharmacology*; D013788:Thalamus / Q000166:cytology* / Q000378:metabolism; D010738:Type C Phospholipases / Q000378:metabolism / Q000494:pharmacology
chemical_list: D012794:Sialic Acids; C021319:polysialic acid; D010738:Type C Phospholipases; D006026:Glycoside Hydrolases; C090534:endo-alpha-sialidase; D002810:Chondroitinases and Chondroitin Lyases; D043265:Phosphatidylinositol Diacylglycerol-Lyase